Tissue biomarkers as predictors of outcome and selection of transplant candidates with hepatocellular carcinoma
- PMID: 21594967
- PMCID: PMC3164216
- DOI: 10.1002/lt.22340
Tissue biomarkers as predictors of outcome and selection of transplant candidates with hepatocellular carcinoma
References
-
- Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. NEJM. 1996;334:693–699. - PubMed
-
- Llovet JM, Schwartz M, Mazzaferro V. Resection and transplantation for HCC. Sem Liv Dis. 2005;2:181–200. - PubMed
-
- Mazzaferro V, Llovet J, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: an exploratory analysis. Lancet Oncology. 2009;10(1):35–43. - PubMed
-
- Poon RT, Ho JW, Tong CS, et al. Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma. Br J Surg. 2004;91:1354–1360. - PubMed
-
- Nakanishi K, Sakamoto M, Yamasaki S, et al. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellularr carcinoma. Cancer. 2005;103:307–312. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical